Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MB 157
Unknown
Unknown
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7482.095
uM
0.45491
0.21241
0.3008 0.2970 1.1838 0.5367
0.9244
2.2108
MB 157
Unknown
Unknown
PS-1145
IKK
NFKB
7482.065
uM
inf
inf
0.9413 0.9413 0.0000 0.0141
0.0523
2.2390
MB 157
Unknown
Unknown
Purvalanol A
CDK1
CDK
7482.067
uM
1.75670
1.74740
0.1498 0.0132 5.0000 0.4222
0.7450
1.9350
MB 157
Unknown
Unknown
SB-3CT
MMP2/9
MMP
12580.168
uM
inf
999.49420
0.9016 0.7834 0.1339 0.0552
0.5863
2.0973
MB 157
Unknown
Unknown
Selumetinib
MEK
MAPK
12580.155
uM
0.26308
0.08392
0.2460 0.2091 0.4742 0.3920
0.9920
2.2315
MB 157
Unknown
Unknown
Sigma A6730
AKT
AKT
12580.165
uM
13.33510
15.84260
-0.6815 -0.6828 4.9970 0.1959
0.9769
2.2883
MB 157
Unknown
Unknown
Sirolimus
MTOR
MTOR
9039.068
uM
inf
inf
0.0730 0.0730 0.0000 0.5500
0.5032
0.4510
MB 157
Unknown
Unknown
Sirolimus
MTOR
MTOR
7482.069
uM
inf
0.02594
0.7163 0.7222 1.5641 0.1554
0.9762
2.1744
MB 157
Unknown
Unknown
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7482.084
uM
inf
inf
1.0106 1.0106 0.0000 -0.0449
-13.5536
1.8697
MB 157
Unknown
Unknown
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7482.067
uM
3.83970
8.99340
-0.9514 -1.0000 1.2908 0.5341
0.9614
1.9350
MB 157
Unknown
Unknown
TCS 2312
CHK1
CHK
12580.152
uM
0.39369
0.40867
-0.1760 -0.1026 5.0000 0.3574
0.9921
2.2597
MB 157
Unknown
Unknown
TCS PIM-1 1
Pim kinase
PIM
12580.135
uM
inf
150.77040
0.8333 0.5221 4.9812 -0.0078
0.7813
2.1782
MB 157
Unknown
Unknown
Temsirolimus
MTOR
MTOR
12580.168
uM
0.52601
19.98360
-0.6679 -1.0000 0.3020 0.5025
0.8114
2.0973
MB 157
Unknown
Unknown
Topotecan
TOP1
TOP
9039.078
uM
0.00994
0.03355
-0.9969 -1.0000 0.9028 1.2872
0.9855
0.6306
MB 157
Unknown
Unknown
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12580.169
uM
0.08297
0.09563
-0.5824 -0.3198 3.4823 0.6951
0.9733
2.1524
MB 157
Unknown
Unknown
Trametinib
MEK
MAPK
9039.05
uM
0.01120
0.01040
-0.2387 0.0220 0.6061 0.5364
0.7586
0.4285
MB 157
Unknown
Unknown
Trichostatin A
HDAC
HDAC
7482.065
uM
10.20190
17.41690
-0.7553 -0.7354 1.6912 0.7724
0.9990
2.2390
MB 157
Unknown
Unknown
Triciribine
AKT
AKT
7482.074
uM
2.67840
317.77670
0.2035 -1.0000 0.2300 0.2827
0.6689
1.7663
MB 157
Unknown
Unknown
Valproic acid
HDAC
HDAC
12580.143
uM
3111.8610
999.99970
0.1758 0.3973 1.3940 0.0819
0.7946
2.2318
MB 157
Unknown
Unknown
Vorinostat
HDAC
HDAC
7482.065
uM
103.49220
292.37470
-0.7311 -0.7760 0.9021 0.5820
0.9995
2.2390
MB 157
Unknown
Unknown
XRP44X
ELK3
MAPK
12580.171
uM
1.35870
1.36780
-0.0074 -0.0072 2.1297 0.3610
0.9996
2.0272
MB 157
Unknown
Unknown
ZM-447439
AURK
AURK
12580.169
uM
0.75556
0.81963
-0.3346 -0.2512 5.0000 0.3762
0.9926
2.1524
MCF 10A
NM
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
9551.132
uM
inf
inf
0.8030 0.8030 0.0000 0.0980
0.1523
2.8612
MCF 10A
NM
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7870.016
uM
136.89090
165.87320
0.0816 -0.8061 5.0000 0.0251
0.9788
2.1045
MCF 10A
NM
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7867.016
uM
26.1280
31.13250
-0.7005 -0.7009 5.0000 0.2035
0.9964
2.2657